Gambacorti-Passerini, C., Brümmendorf, T. H., Kim, D., Turkina, A. G., Masszi, T., Assouline, S., . . . Cortes, J. E. (2014). Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up. Blackwell Publishing Ltd.
Stile di citazione ChicagoGambacorti-Passerini, Carlo, et al. Bosutinib Efficacy and Safety in Chronic Phase Chronic Myeloid Leukemia After Imatinib Resistance or Intolerance: Minimum 24-month Follow-up. Blackwell Publishing Ltd, 2014.
Citazione MLAGambacorti-Passerini, Carlo, et al. Bosutinib Efficacy and Safety in Chronic Phase Chronic Myeloid Leukemia After Imatinib Resistance or Intolerance: Minimum 24-month Follow-up. Blackwell Publishing Ltd, 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.